ICD-11 classes
02 Neoplasms
Neoplasms of haematopoietic or lymphoid tissues
Myelodysplastic syndromes
ICD-11 Myelodysplastic syndromes
Clonal hematopoietic disorders characterised by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20% in marrow and blood, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukaemia.
The diagnosis includes nothing.
It excludes 2 items.
- Therapy-related myeloid neoplasms (2A60.2)
- Drug-induced aplastic anaemia (3A70.10)
Diagnosis contains 11 clarifying diagnoses:
- 2A30 — Refractory anaemia
- 2A31 — Refractory neutropaenia
- 2A32 — Refractory thrombocytopenia
- 2A33 — Refractory anaemia with ring sideroblasts
- 2A34 — Refractory cytopenia with multi-lineage dysplasia
- 2A35 — Refractory anaemia with excess of blasts
- 2A36 — Myelodysplastic syndrome with isolated del(5q)
- 2A37 — Myelodysplastic syndrome, unclassifiable
- 2A38 — Refractory cytopenia of childhood
- 2A3Y — Other specified myelodysplastic syndromes
- 2A3Z — Myelodysplastic syndromes, unspecified
The diagnosis is coded elsewhere: